Format

Send to

Choose Destination
Dermatol Ther. 2017 Nov;30(6). doi: 10.1111/dth.12549. Epub 2017 Sep 20.

Treatment of psoriasis with topical agents: Recommendations from a Tuscany Consensus.

Author information

1
Dermatology Department, University of Pisa. Via Roma 67, 56126 Pisa, Italy.
2
Department of Surgery and Translational Medicine, Section of Dermatology and Venereology, University of Florence School of Medicine, Florence, Italy.
3
Dermatology Unit, Livorno Hospital, ASL 6, Livorno, Italy.
4
Dermatology Unit, San Jacopo Hospital, ASL 3, Pistoia, Italy.
5
Dermatology Unit, Carrara Hospital, USL nordovest, Carrara, Italy.
6
Dermatology Unit, San Giuseppe Hospital, ASL 11, Empoli, Italy.
7
Dermatologic Rare Diseases and Skin Immunopathology Unit, University of Florence, Florence, Italy.
8
U.O. Dermatology I, University of Florence, Florence, Italy.
9
Dermatology Unit, San Donato Hospital, ASL 8, Arezzo, Italy.
10
Departmernt of Dermatology, Division of Medical, Surgical and Neurosciences, University of Siena, Siena Italy.
11
Dermatology Unit, Versilia Hospital, ASL 12, Lido di Camaiore, Lucca, Italy.
12
Dermatology Unit, Campo di Marte Hospital, ASL 2, Lucca, Italy.
13
Dermatology Unit, Prato Hospital, ASL 4, Prato, Italy.
14
Dermatology Unit, Misericordia Hospital, ASL 9, Grosseto, Italy.

Abstract

Psoriasis is a chronic and relapsing inflammatory skin disease, clinically characterized by erythematous and scaly plaques. Treatment approach is mainly driven by disease severity, though several factors should be considered in order to identify the optimal therapeutic choice. Mild psoriasis may be treated with a wide array of topical agents including corticosteroids, vitamin D analogs, keratolytics, and calcipotriol/betamethasone propionate compound. Because guidelines may not provide practical indications regarding the therapeutic approach, the use of topical agents in psoriasis is more individually tailored. In order to homogenize the standard of care, at least in a local setting, we collected the real-life-based recommendations for the use of topical therapies from an expert panel, the Tuscany Consensus Group on Psoriasis, representing all leading centers for psoriasis established in Tuscany. With this document, this consensus group sought to define principles guiding the selection of therapeutic agents with straightforward recommendations derived from a real-life setting.

KEYWORDS:

consensus; psoriasis; therapy; topical

PMID:
28940579
DOI:
10.1111/dth.12549
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center